Linear verrucous epidermal nevus

From WikiMD's Medical Encyclopedia

Revision as of 20:25, 21 February 2025 by Prab (talk | contribs) (Management)

A type of skin lesion



Linear verrucous epidermal nevus (LVEN) is a type of epidermal nevus characterized by a linear arrangement of verrucous skin lesions. These lesions are typically present at birth or develop in early childhood and are caused by a genetic mosaicism.

Presentation

Linear verrucous epidermal nevus on the arm

Linear verrucous epidermal nevus presents as a series of hyperkeratotic and verrucous papules that coalesce into linear plaques. These lesions follow the lines of Blaschko's lines, which are patterns of skin cell development. The lesions are often hyperpigmented and can vary in color from light brown to dark brown or black.

Pathophysiology

LVEN is caused by a postzygotic mutation leading to genetic mosaicism. This results in a localized area of skin cells that proliferate abnormally, forming the characteristic lesions. The exact genetic mutations involved can vary, but they often affect genes related to skin cell growth and differentiation.

Diagnosis

Diagnosis of linear verrucous epidermal nevus is primarily clinical, based on the appearance and distribution of the lesions. A skin biopsy may be performed to confirm the diagnosis and rule out other conditions. Histologically, the lesions show acanthosis, hyperkeratosis, and papillomatosis.

Management

Management of LVEN is often conservative, as the lesions are benign. However, treatment may be sought for cosmetic reasons or if the lesions become symptomatic. Options include:

Prognosis

The prognosis for individuals with linear verrucous epidermal nevus is generally good, as the condition is benign. However, there is a small risk of malignant transformation in long-standing lesions, so regular monitoring is recommended.

Related pages

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.